The company will provide one crore tablets every week, starting from today 12th May 2021, aggregating to 16 crore tablets worth Rs 8 crores over next four months.
A Fast Trak lab will be established in the Genome Valley for Biopharma scale up, professional training, technology evaluation, consultancy services and infrastructure support for process development.
The company believes that the warning letter will have minimum impact of disruption of supplies and the existing revenues from operations of this facility.
The company, through an initiative named Sai Nxt, is investing over $150 million (> Rs 1000 crores) to expand and upgrade its R&D and manufacturing capabilities.